Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Availability of Poxel's 2022 Half-Year Financial Report: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Availability of Poxel's 2022 Half-Year Financial Report


POXEL SA (Euronext: POXEL - FR0012432516), a clinical-stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including

Kaufman & Broad SA: RESULTS OF THE FIRST NINE MONTHS OF THE 2022 BUSINESS YEAR
Kaufman & Broad SA: RESULTS OF THE FIRST NINE MONTHS OF THE 2022 BUSINESS YEAR
Kaufman & Broad SA: RESULTS OF THE FIRST NINE MONTHS OF THE 2022 BUSINESS YEAR
EQS-News: ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022
EQS-News: ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022
EQS-News: ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022
Poxel Announces PXL770 Granted Orphan Drug Designation from the U.S. FDA for Autosomal-Dominant Polycystic Kidney Disease (ADPKD): https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces PXL770 Granted Orphan Drug Designation from the U.S. FDA for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)


POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

EQS-News: ABIVAX ANNOUNCES THE RELEASE OF ITS 2022  HALF-YEAR FINANCIAL REPORT
EQS-News: ABIVAX ANNOUNCES THE RELEASE OF ITS 2022 HALF-YEAR FINANCIAL REPORT
EQS-News: ABIVAX ANNOUNCES THE RELEASE OF ITS 2022 HALF-YEAR FINANCIAL REPORT
FITCH ASSIGNS AN INVESTMENT GRADE BBB- RATING TO KAUFMAN & BROAD
FITCH ASSIGNS AN INVESTMENT GRADE BBB- RATING TO KAUFMAN & BROAD
FITCH ASSIGNS AN INVESTMENT GRADE BBB- RATING TO KAUFMAN & BROAD
Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022


Regulatory News:



NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

EQS-News: ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022
EQS-News: ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022
EQS-News: ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022
R&D Day: Presentations to Highlight Transgene’s Competitive Positioning, Capabilities to Engineer Novel Immunotherapies for Patients with Cancer, and Update on Initial Clinical Data: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
R&D Day: Presentations to Highlight Transgene’s Competitive Positioning, Capabilities to Engineer Novel Immunotherapies for Patients with Cancer, and Update on Initial Clinical Data


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, will host today an R&D event for investors

Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022


Regulatory News:



NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy


Regulatory News:



NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

Poxel Reports Financial Results for First Half 2022 and Provides a Corporate Update: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Reports Financial Results for First Half 2022 and Provides a Corporate Update


POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone


POXEL SA (Euronext : POXEL - FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

Streamkeeper von Verimatrix erzielt höchste Auszeichnung bei den CSI Awards 2022: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Streamkeeper von Verimatrix erzielt höchste Auszeichnung bei den CSI Awards 2022


Verimatrix (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass seine Lösung Verimatrix

Verimatrix Streamkeeper Takes Home Top Honor in 2022 CSI Awards: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Streamkeeper Takes Home Top Honor in 2022 CSI Awards


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix Streamkeeper was

DGAP-News: Abivax presents first-half 2022 financial results and operations update
DGAP-News: Abivax presents first-half 2022 financial results and operations update
DGAP-News: Abivax presents first-half 2022 financial results and operations update
Verimatrix-Technologien zur Bedrohungsabwehr im Einsatz bei führendem Online-Shopping-Service Saudi-Arabiens: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix-Technologien zur Bedrohungsabwehr im Einsatz bei führendem Online-Shopping-Service Saudi-Arabiens


Verimatrix (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, teilte heute mit, dass Jarir, Saudi-Arabiens größter E-Commerce-

Verimatrix Threat Defense Technologies Deployed by Saudi Arabia’s Largest Online Shopping Service: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Threat Defense Technologies Deployed by Saudi Arabia’s Largest Online Shopping Service


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Jarir, Saudi Arabia’s largest ecommerce

Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024


Regulatory News:



NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022 : https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces positive confirmatory data

NexPlayer bietet leistungsstarke Kombination aus Videoqualität und Schutz durch Integration von Verimatrix Streamkeeper und Watermarking: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
NexPlayer bietet leistungsstarke Kombination aus Videoqualität und Schutz durch Integration von Verimatrix Streamkeeper und Watermarking


Pflichtmitteilung:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass NexPlayer mit Sitz in

NexPlayer To Offer Powerful Combination of Video Quality and Protection through Integration with Verimatrix Streamkeeper and Watermarking: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
NexPlayer To Offer Powerful Combination of Video Quality and Protection through Integration with Verimatrix Streamkeeper and Watermarking


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Madrid-based NexPlayer has

Fastway setzt Verimatrix Content-Sicherheitstechnologie in neuen Google Android Set-Top-Boxen ein: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Fastway setzt Verimatrix Content-Sicherheitstechnologie in neuen Google Android Set-Top-Boxen ein


Verimatrix, (Euronext Paris: VMX), der Marktführer, wenn es um die Ausstattung der modernen vernetzten Welt mit Sicherheitsfunktionen geht, die den Menschen in den Mittelpunkt stellen, kündigt

Nanobiotix: Voting Rights and Shares Capital of the Company: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix: Voting Rights and Shares Capital of the Company


Regulatory News:



Nanobiotix (Paris:NANO) (NASDAQ:NBTX):



Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website

Fastway To Deploy Verimatrix Content Security Technology within New Google Android Set-Top Boxes: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Fastway To Deploy Verimatrix Content Security Technology within New Google Android Set-Top Boxes


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Fastway Transmissions Private Limited